Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Palvella Therapeutics, Inc. (PVLA) Debt to Capital Ratio data is not available.
| Income Statement Financials | |
-- |
|
$-21.87M |
|
-- |
|
-- |
|
$21.41M |
|
$-21.41M |
|
$-0.47M |
|
$-21.87M |
|
$-21.87M |
|
$-21.87M |
|
$-21.87M |
|
$-21.87M |
|
$-21.87M |
|
$-21.41M |
|
$-21.41M |
|
14.36M |
|
14.36M |
|
$-1.52 |
|
$-1.52 |
|
| Balance Sheet Financials | |
$253.03M |
|
-- |
|
$0.48M |
|
$253.51M |
|
$11.95M |
|
-- |
|
$24.70M |
|
$36.64M |
|
$216.87M |
|
$216.87M |
|
$216.87M |
|
14.40M |
|
| Cash Flow Statement Financials | |
$-23.71M |
|
$-62.47M |
|
$216.01M |
|
$57.98M |
|
$187.80M |
|
$129.82M |
|
$8.53M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
21.18 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-23.71M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-10.08% |
|
-10.08% |
|
-8.63% |
|
-10.08% |
|
$15.06 |
|
$-1.65 |
|
$-1.65 |
|